Background
EROSIVE OESOPHAGITIS
Vonoprazan is a potassium-competitive acid blocker which, unlike conventional PPIs, reversibly inhibits the enzyme HSince long-term maintenance treatment is recommended for patients with erosive oesophagitis [Although the safety and efficacy of vonoprazan as maintenance therapy have been previously reported in a 52-week study [